ATE370122T1 - 6-methylpyridinderivat, verfahren zu seiner herstellung und es enthaltende antivirale pharmazeutische zusammensetzung - Google Patents
6-methylpyridinderivat, verfahren zu seiner herstellung und es enthaltende antivirale pharmazeutische zusammensetzungInfo
- Publication number
- ATE370122T1 ATE370122T1 AT03807998T AT03807998T ATE370122T1 AT E370122 T1 ATE370122 T1 AT E370122T1 AT 03807998 T AT03807998 T AT 03807998T AT 03807998 T AT03807998 T AT 03807998T AT E370122 T1 ATE370122 T1 AT E370122T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- production
- composition containing
- containing same
- antiviral pharmaceutical
- Prior art date
Links
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical class CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 title abstract 4
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 241000711549 Hepacivirus C Species 0.000 abstract 3
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 230000010076 replication Effects 0.000 abstract 2
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2002-0061994A KR100453946B1 (ko) | 2002-10-11 | 2002-10-11 | 6-메틸피리딘 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE370122T1 true ATE370122T1 (de) | 2007-09-15 |
Family
ID=32089702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03807998T ATE370122T1 (de) | 2002-10-11 | 2003-10-02 | 6-methylpyridinderivat, verfahren zu seiner herstellung und es enthaltende antivirale pharmazeutische zusammensetzung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7244731B2 (de) |
| EP (1) | EP1549642B1 (de) |
| JP (1) | JP2006506358A (de) |
| KR (1) | KR100453946B1 (de) |
| CN (1) | CN100355752C (de) |
| AT (1) | ATE370122T1 (de) |
| AU (1) | AU2003265122B2 (de) |
| BR (1) | BR0314478A (de) |
| CA (1) | CA2499642A1 (de) |
| DE (1) | DE60315685D1 (de) |
| MX (1) | MXPA05003159A (de) |
| WO (1) | WO2004033450A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004050283A1 (de) | 2004-10-15 | 2006-04-27 | Lanxess Deutschland Gmbh | 4-Aminophenyl-morpholinon-Derivate und deren Herstellung |
| EP2494991A1 (de) | 2007-05-04 | 2012-09-05 | Vertex Pharmaceuticals Incorporated | Kombinationstherapie zur Behandlung von HIV-Infektionen |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2187317B2 (de) * | 1972-06-07 | 1975-06-20 | Hexachimie | |
| US3878206A (en) * | 1973-06-06 | 1975-04-15 | Morton Norwich Products Inc | 9-(Substituted amino)imidazo{8 4,5-f{9 quinolines |
| CA1263378A (en) * | 1985-01-08 | 1989-11-28 | Robert James Alaimo | Imidazo¬4,5-f|quinolines useful as immunomodulating agents |
| KR100566193B1 (ko) * | 1999-11-27 | 2006-03-29 | 동화약품공업주식회사 | 신규의 3-니트로피리딘 유도체 및 그를 포함하는 약학적조성물 |
| KR100566194B1 (ko) * | 1999-12-29 | 2006-03-29 | 동화약품공업주식회사 | 신규의 3-니트로피리딘 유도체 및 그를 포함하는 약학적조성물 |
| US6608058B2 (en) | 2000-04-17 | 2003-08-19 | Dong Wha Pharm. Ind. Co., Ltd. | 6-methylnicotinamide derivatives as antiviral agents |
| JP2004526756A (ja) * | 2001-04-06 | 2004-09-02 | スミスクライン ビーチャム コーポレーション | ｈＹＡＫ１及びｈＹＡＫ３キナーゼのキノリン阻害剤 |
-
2002
- 2002-10-11 KR KR10-2002-0061994A patent/KR100453946B1/ko not_active Expired - Fee Related
-
2003
- 2003-10-02 CA CA002499642A patent/CA2499642A1/en not_active Abandoned
- 2003-10-02 JP JP2004542896A patent/JP2006506358A/ja not_active Ceased
- 2003-10-02 DE DE60315685T patent/DE60315685D1/de not_active Expired - Lifetime
- 2003-10-02 CN CNB2003801007489A patent/CN100355752C/zh not_active Expired - Fee Related
- 2003-10-02 US US10/528,461 patent/US7244731B2/en not_active Expired - Fee Related
- 2003-10-02 EP EP03807998A patent/EP1549642B1/de not_active Expired - Lifetime
- 2003-10-02 WO PCT/KR2003/002034 patent/WO2004033450A1/en not_active Ceased
- 2003-10-02 AU AU2003265122A patent/AU2003265122B2/en not_active Ceased
- 2003-10-02 AT AT03807998T patent/ATE370122T1/de not_active IP Right Cessation
- 2003-10-02 BR BR0314478-0A patent/BR0314478A/pt not_active IP Right Cessation
- 2003-10-02 MX MXPA05003159A patent/MXPA05003159A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7244731B2 (en) | 2007-07-17 |
| CN100355752C (zh) | 2007-12-19 |
| WO2004033450A1 (en) | 2004-04-22 |
| EP1549642B1 (de) | 2007-08-15 |
| AU2003265122A1 (en) | 2004-05-04 |
| BR0314478A (pt) | 2005-07-26 |
| DE60315685D1 (de) | 2007-09-27 |
| KR100453946B1 (ko) | 2004-10-20 |
| EP1549642A1 (de) | 2005-07-06 |
| CN1694880A (zh) | 2005-11-09 |
| AU2003265122B2 (en) | 2006-11-02 |
| EP1549642A4 (de) | 2006-09-20 |
| CA2499642A1 (en) | 2004-04-22 |
| JP2006506358A (ja) | 2006-02-23 |
| KR20040033099A (ko) | 2004-04-21 |
| US20060269609A1 (en) | 2006-11-30 |
| MXPA05003159A (es) | 2005-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006046039A3 (en) | Tetracyclic indole derivatives as antiviral agents | |
| MY128463A (en) | 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus | |
| WO2007029029A3 (en) | Tetracyclic indole derivatives as antiviral agents | |
| WO2008021928A3 (en) | Hepatitis c virus inhibitors | |
| NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
| WO2004043337A3 (en) | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides | |
| WO2002100415A3 (en) | 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus | |
| MXPA06000418A (es) | Derivados de ariltiourea sustituida utiles como inhibidores de duplicacion viral. | |
| DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
| WO2003037860A3 (en) | Purine analogs having hsp90-inhibiting activity | |
| DE60215157D1 (de) | Verwendungen von antiviralen nucleosid-derivaten zur herstellung eines medikaments zur behandlung von hepatitis c infektionen | |
| ATE229017T1 (de) | Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung | |
| NO20060981L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
| WO2001027111A3 (de) | Bicyclische imidazo-3-yl-aminderivate | |
| MXPA03005464A (es) | Agentes antivirales. | |
| WO2005069933A3 (en) | Methods of treating an inflammatory-related disease | |
| ATE450533T1 (de) | Carboxamidderivate | |
| MY127718A (en) | Dolastatin 10 derivatives. | |
| SE0104341D0 (sv) | New use | |
| WO2006027628A3 (en) | Naphthalimide derivatives as antiviral agents | |
| ATE386725T1 (de) | Heterocyclylverbindungen | |
| ATE372995T1 (de) | Benzo(b)(1,4)dioxepinderivate | |
| ATE466008T1 (de) | P-glycoprotein-inhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält | |
| NO20052683L (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| WO2001027110A3 (de) | Am sechsring substituierte, bicyclische imidazo-3-yl-aminderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |